Aspira Women`s Health Inc
NASDAQ:AWH 3:59:45 PM EDT
| Market Cap (Intraday) | 775.26M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $6.35 |
| 50-Day MA | $5.52 |
| 200-Day MA | $3.82 |
VERMILLION, INC. Stock, NASDAQ:AWH
12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX 78738
United States of America
Phone: 512-519-0400
Number of Employees: 43
Description
Aspira Women's Health Inc., together with its subsidiaries, discovers, develops, and commercializes diagnostic and bio-analytical solutions that help physicians to diagnose, treat, and enhance outcomes for women. It is developing novel diagnostic tests for gynecologic disease with focus on ovarian cancer. The company's lead in vitro diagnostic test is Overa, a blood test to aid physicians in pre-surgical assessment of ovarian tumors for malignancy, using an ialgorithmic approach. It serves clinical reference laboratories, hospital laboratories, and physician offices in the United States. Vermillion, Inc. was founded in 1993 and is headquartered in Austin, Texas.